A Polymorphism of a Platelet Glycoprotein Receptor as an Inherited Risk Factor for Coronary Thrombosis
Ethan J. Weiss, B.A., Paul F. Bray, M.D., Matthew Tayback, Sc.D., Steven P. Schulman, M.D., Thomas S. Kickler, M.D., Lewis C. Becker, M.D., James L. Weiss, M.D., Gary Gerstenblith, M.D., and Pascal J. Goldschmidt-Clermont, M.D.
Background Platelet glycoprotein IIb/IIIa is a membrane receptorfor fibrinogen and von Willebrand factor, and it has an importantrole in platelet aggregation. It is known to be involved inthe pathogenesis of acute coronary syndromes. Previously, wefound a high frequency of a particular polymorphism, PlA2, ofthe gene encoding glycoprotein IIIa in kindreds with a highprevalence of premature myocardial infarction.
Methods To investigate the relation between the PlA2polymorphismand acute coronary syndromes, we conducted a casecontrolstudy of 71 case patients with myocardial infarction or unstableangina and 68 inpatient controls without known heart disease.The groups were matched for age, race, and sex. We used twomethods to determine the PlA genotype: reverse dot blot hybridizationand allele-specific restriction digestion.
Results The prevalence of PlA2 was 2.1 times higher among thecase patients than among the controls (39.4 percent vs. 19.1percent, P = 0.01). In a subgroup of patients whose diseasebegan before the age of 60 years, the prevalence of PlA2was50 percent, a value that was 3.6 times that among control subjectsunder 60 years of age (13.9 percent, P = 0.002). Among subjectswith the PlA2 polymorphism, the odds ratio for having a coronaryevent was 2.8 (95 percent confidence interval, 1.2 to 6.4).In the patients less than 60 years of age at the onset of disease,the odds ratio was 6.2 (95 percent confidence interval, 1.8to 22.4).
Conclusions We observed a strong association between the PlA2polymorphism of the glycoprotein IIIa gene and acute coronarythrombosis, and this association was strongest in patients whohad had coronary events before the age of 60 years.
Source Information
From the Department of Medicine, Divisions of Cardiology (E.J.W., S.P.S., L.C.B., J.L.W., G.G., P.J.G.-C.) and Hematology (E.J.W., P.F.B., T.S.K.), the Department of Pathology (P.F.B., T.S.K.), and the Department of Cell Biology and Anatomy (P.J.G.-C.), Johns Hopkins University School of Medicine; and Johns Hopkins University School of Hygiene and Public Health (M.T.) both in Baltimore.
Address reprint requests to Dr. Goldschmidt-Clermont at Bernard Laboratory, Ross 1023, Johns Hopkins Medical School, 720 Rutland Ave., Baltimore, MD 21205.
Kumar, A., Cannon, C. P.
(2009). Acute Coronary Syndromes: Diagnosis and Management, Part I. Mayo Clin Proc.
84: 917-938
[Abstract][Full Text]
CHIRAS, T., PAPADAKIS, E. D., KATOPODI, A., CHATZIANESTI, E., FOURTOUNAS, K., PAPAKONSTANTINOU, S., THEODOROPOULOS, I., DAKOURAS, A., ZEREFOS, N., VALIS, D., TZANATOS-EXARCHOU, H.
(2009). Platelet GP IIIA Polymorphism HPA-1 (PLA1/2) Is Associated with Hypertension as the Primary Cause for End-stage Renal Disease in Hemodialysis Patients from Greece. In Vivo
23: 177-181
[Abstract][Full Text]
Rossouw, J. E., Cushman, M., Greenland, P., Lloyd-Jones, D. M., Bray, P., Kooperberg, C., Pettinger, M., Robinson, J., Hendrix, S., Hsia, J.
(2008). Inflammatory, Lipid, Thrombotic, and Genetic Markers of Coronary Heart Disease Risk in the Women's Health Initiative Trials of Hormone Therapy. Arch Intern Med
168: 2245-2253
[Abstract][Full Text]
Lambrinoudaki, I., Kaparos, G., Papadimitriou, D., Sergentanis, T. N, Creatsa, M., Alexandrou, A., Logothetis, E., Christodoulakos, G., Kouskouni, E
(2008). Methylenetetrahydrofolate reductase C677T polymorphism is associated with central adiposity and increased androgenicity in healthy postmenopausal women. Eur J Endocrinol
159: 233-241
[Abstract][Full Text]
Medina, P., Navarro, S., Corral, J., Zorio, E., Roldan, V., Estelles, A., Santamaria, A., Marin, F., Rueda, J., Bertina, R. M., Espana, F., for the RECAVA Thrombosis Groups,
(2008). Endothelial protein C receptor polymorphisms and risk of myocardial infarction. haematol
93: 1358-1363
[Abstract][Full Text]
Jimenez, S, Tassies, D, Espinosa, G, Garcia-Criado, A, Plaza, J, Monteagudo, J, Cervera, R, Reverter, J C
(2008). Double heterozygosity polymorphisms for platelet glycoproteins Ia/IIa and IIb/IIIa increases arterial thrombosis and arteriosclerosis in patients with the antiphospholipid syndrome or with systemic lupus erythematosus. Ann Rheum Dis
67: 835-840
[Abstract][Full Text]
Chandrakantan, A., McDermott, D. H., Bich Tran, H. T., Jurewicz, M., Gallon, L., Gaston, R., Milford, E., Abdi, R.
(2007). Role of {beta}3 Integrin in Acute Renal Allograft Rejection in Humans. CJASN
2: 1268-1273
[Abstract][Full Text]
Momary, K. M.
(2007). Cardiovascular Pharmacogenomics. Journal of Pharmacy Practice
20: 265-276
[Abstract]
Wierman, M. E., Kohrt, W. M.
(2007). Review Article: Vascular and Metabolic Effects of Sex Steroids: New Insights Into Clinical Trials. Reproductive Sciences
14: 300-314
[Abstract]
Ostojic, L., Zelenika, D., Zotz, R.B., Sucker, C., Ostojic, Z., Loncar, R.
(2007). Platelet Receptor HPA-1 Polymorphism of {alpha}IIb{beta}3 and 807 C/T Polymorphism of {alpha}2{beta}1 and Buerger's Disease. ANGIOLOGY
58: 169-174
[Abstract]
Undas, A., Brummel-Ziedins, K. E., Mann, K. G.
(2007). Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions. Blood
109: 2285-2292
[Abstract][Full Text]
Berge, E., Haug, K. B. F., Charlotte Sandset, E., Kristine Haugbro, K., Turkovic, M., Sandset, P. M.
(2007). The Factor V Leiden, Prothrombin Gene 20210GA, Methylenetetrahydrofolate Reductase 677CT and Platelet Glycoprotein IIIa 1565TC Mutations in Patients With Acute Ischemic Stroke and Atrial Fibrillation. Stroke
38: 1069-1071
[Abstract][Full Text]
Lim, E., Carballo, S., Cornelissen, J., Ali, Z. A., Grignani, R., Bellm, S., Large, S.
(2007). Dose-Related Efficacy of Aspirin After Coronary Surgery in Patients With PlA2 Polymorphism (NCT00262275). Ann. Thorac. Surg.
83: 134-138
[Abstract][Full Text]
Oksala, N. K.J., Heikkinen, M., Mikkelsson, J., Pohjasvaara, T., Kaste, M., Erkinjuntti, T., Karhunen, P. J.
(2007). Smoking and the Platelet Fibrinogen Receptor Glycoprotein IIb/IIIA PlA1/A2 Polymorphism Interact in the Risk of Lacunar Stroke and Midterm Survival. Stroke
38: 50-55
[Abstract][Full Text]
Ndrepepa, G., Kastrati, A., Mehilli, J., Neumann, F.-J., ten Berg, J., Bruskina, O., Dotzer, F., Seyfarth, M., Pache, J., Dirschinger, J., Ulm, K., Berger, P. B., Schomig, A.
(2006). Age-Dependent Effect of Abciximab in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Interventions. Circulation
114: 2040-2046
[Abstract][Full Text]
Mathew, J. P., Rinder, H. M., Smith, B. R., Newman, M. F., Rinder, C. S.
(2006). Transcerebral Platelet Activation After Aortic Cross-Clamp Release is Linked to Neurocognitive Decline.. Ann. Thorac. Surg.
81: 1644-1649
[Abstract][Full Text]
Vijayan, K. V., Bray, P. F.
(2006). Molecular Mechanisms of Prothrombotic Risk Due to Genetic Variations in Platelet Genes: Enhanced Outside-In Signaling Through the Pro33 Variant of Integrin {beta}3.. Exp. Biol. Med.
231: 505-513
[Abstract][Full Text]
Koh, K. K., Yoon, B.-K.
(2006). Controversies regarding hormone therapy: Insights from inflammation and hemostasis. Cardiovasc Res
70: 22-30
[Abstract][Full Text]
Kubisz, P., Ivankova, J., Holly, P., Stasko, J., Musia/l, J.
(2006). The Glycoprotein IIIa PLA1/A2 Polymorphism--A Defect Responsible for the Sticky Platelet Syndrome?. CLIN APPL THROMB HEMOST
12: 117-119
Podgoreanu, M. V., Schwinn, D. A.
(2005). New Paradigms in Cardiovascular Medicine: Emerging Technologies and Practices: Perioperative Genomics. J Am Coll Cardiol
46: 1965-1977
[Abstract][Full Text]
Yee, D. L., Sun, C. W., Bergeron, A. L., Dong, J.-f., Bray, P. F.
(2005). Aggregometry detects platelet hyperreactivity in healthy individuals. Blood
106: 2723-2729
[Abstract][Full Text]
Papp, E., Havasi, V., Bene, J., Komlosi, K., Czopf, L., Magyar, E., Feher, C., Feher, G., Horvath, B., Marton, Z., Alexy, T., Habon, T., Szabo, L., Toth, K., Melegh, B.
(2005). Glycoprotein IIIA Gene (PlA) Polymorphism and Aspirin Resistance: Is There Any Correlation?. The Annals of Pharmacotherapy
39: 1013-1018
[Abstract][Full Text]
MacCallum, P. K.
(2005). Markers of Hemostasis and Systemic Inflammation in Heart Disease and Atherosclerosis in Smokers. Proc Am Thorac Soc
2: 34-43
[Abstract][Full Text]
Amit, G., Yermiyahu, T., Gilutz, H., Ilia, R., Zahger, D.
(2005). Thrombocytopenia, Immunoglobulin Treatment, and Acute Myocardial Infarction: A Case Report. ANGIOLOGY
56: 229-231
[Abstract]
Ginsburg, D.
(2005). Genetic Risk Factors for Arterial Thrombosis and Inflammation. ASH Education Book
2005: 442-444
[Abstract][Full Text]
Samaha, F. F., Hibbard, C., Sacks, J., Chen, H., Varello, M. A., George, T., Kahn, M. L.
(2004). Measurement of Platelet Collagen Receptor Density in Human Subjects. Arterioscler. Thromb. Vasc. Bio.
24: e181-e182
[Full Text]
Schulman, S. P.
(2004). Antiplatelet Therapy in Non-ST-Segment Elevation Acute Coronary Syndromes. JAMA
292: 1875-1882
[Abstract][Full Text]
Iniesta, J. A., Gonzalez-Conejero, R., Piqueras, C., Vicente, V., Corral, J.
(2004). Platelet GP IIIa Polymorphism HPA-1 (PlA) Protects Against Subarachnoid Hemorrhage. Stroke
35: 2282-2286
[Abstract][Full Text]
Xiong, J.-P., Stehle, T., Goodman, S. L., Arnaout, M. A.
(2004). A Novel Adaptation of the Integrin PSI Domain Revealed from Its Crystal Structure. J. Biol. Chem.
279: 40252-40254
[Abstract][Full Text]
Houel, R., Mazoyer, E., Boval, B., Kirsch, M., Vermes, E., Drouet, L., Loisance, D. Y.
(2004). Platelet activation and aggregation profile in prolonged external ventricular support. J. Thorac. Cardiovasc. Surg.
128: 197-202
[Abstract][Full Text]
Koh, K. K., Sakuma, I.
(2004). Should Progestins Be Blamed for the Failure of Hormone Replacement Therapy to Reduce Cardiovascular Events in Randomized Controlled Trials?. Arterioscler. Thromb. Vasc. Bio.
24: 1171-1179
[Abstract][Full Text]
Slowik, A., Dziedzic, T., Turaj, W., Pera, J., Glodzik-Sobanska, L., Szermer, P., Malecki, M. T., Figlewicz, D. A., Szczudlik, A.
(2004). A2 Alelle of GpIIIa Gene Is a Risk Factor for Stroke Caused by Large-Vessel Disease in Males. Stroke
35: 1589-1593
[Abstract][Full Text]
Narizhneva, N. V., Byers-Ward, V. J., Quinn, M. J., Zidar, F. J., Plow, E. F., Topol, E. J., Byzova, T. V.
(2004). Molecular and Functional Differences Induced in Thrombospondin-1 by the Single Nucleotide Polymorphism Associated with the Risk of Premature, Familial Myocardial Infarction. J. Biol. Chem.
279: 21651-21657
[Abstract][Full Text]
Eriksson, A.-L., Skrtic, S., Niklason, A., Hulten, L. M., Wiklund, O., Hedner, T., Ohlsson, C.
(2004). Association between the low activity genotype of catechol-O-methyltransferase and myocardial infarction in a hypertensive population. Eur Heart J
25: 386-391
[Abstract][Full Text]
Potapov, E. V., Ignatenko, S., Nasseri, B. A., Loebe, M., Harke, C., Bettmann, M., Doller, A., Regitz-Zagrosek, V., Hetzer, R.
(2004). Clinical significance of PlA polymorphism of platelet GP IIb/IIIa receptors during long-term VAD support. Ann. Thorac. Surg.
77: 869-874
[Abstract][Full Text]
Voetsch, B., Loscalzo, J.
(2004). Genetic Determinants of Arterial Thrombosis. Arterioscler. Thromb. Vasc. Bio.
24: 216-229
[Abstract][Full Text]
Macchi, L., Christiaens, L., Brabant, S., Sorel, N., Ragot, S., Allal, J., Mauco, G., Brizard, A.
(2003). Resistance in vitro to low-dose aspirin is associated with platelet PlA1 (GP IIIa) polymorphism but not with C807T(GP Ia/IIa) and C-5T kozak (GP Ib{alpha}) polymorphisms. J Am Coll Cardiol
42: 1115-1119
[Abstract][Full Text]
Bojesen, S. E., Juul, K., Schnohr, P., Tybjaerg-Hansen, A., Nordestgaard, B.o. G.
(2003). Platelet glycoprotein IIb/IIIa PlA2/PlA2 homozygosity associated with risk of ischemic cardiovascular disease and myocardial infarction in young men: The Copenhagen City Heart Study. J Am Coll Cardiol
42: 661-667
[Abstract][Full Text]
Tolusso, B, Fabris, M, Gremese, E, Mosca, M, Rovere-Querini, P, Ferraccioli, G F
(2003). Platelet GPIIb/IIIa (P1A1/2) polymorphism in SLE: clinical and laboratory association. Ann Rheum Dis
62: 781-782
[Full Text]
Atherosclerosis, Thrombosis, and Vascular Biology,
(2003). No Evidence of Association Between Prothrombotic Gene Polymorphisms and the Development of Acute Myocardial Infarction at a Young Age. Circulation
107: 1117-1122
[Abstract][Full Text]
Pontiggia, L., Lassila, R., Pederiva, S., Schmid, H.-R., Burger, M., Beer, J. H.
(2002). Increased Platelet-Collagen Interaction Associated With Double Homozygosity for Receptor Polymorphisms of Platelet GPIa and GPIIIa. Arterioscler. Thromb. Vasc. Bio.
22: 2093-2098
[Abstract][Full Text]
Leebeek, F.W.G., Boersma, E., Cannon, C.P., van de Werf, F.J.J., Simoons, M.L.
(2002). Oral glycoprotein IIb/IIIa receptor inhibitors in patients with cardiovascular disease: why were the results so unfavourable. Eur Heart J
23: 444-457
[Full Text]
Braunstein, J. B., Kershner, D. W., Bray, P., Gerstenblith, G., Schulman, S. P., Post, W. S., Blumenthal, R. S.
(2002). Interaction of Hemostatic Genetics With Hormone Therapy : New Insights To Explain Arterial Thrombosis in Postmenopausal Women. Chest
121: 906-920
[Abstract][Full Text]
Benze, G., Heinrich, J., Schulte, H., Rust, S., Nowak-Gottl, U., Tataru, M.-C., Kohler, E., Assmann, G., Junker, R.
(2002). Association of the GPIa C807T and GPIIIa PlA1/A2 polymorphisms with premature myocardial infarction in men. Eur Heart J
23: 325-330
[Abstract][Full Text]
Herrington, D. M., Klein, K. P.
(2001). Genome and Hormones: Gender Differences in Physiology: Invited Review: Pharmacogenetics of estrogen replacement therapy. J. Appl. Physiol.
91: 2776-2784
[Abstract][Full Text]
O'Connor, F. F., Shields, D. C., Fitzgerald, A., Cannon, C. P., Braunwald, E., Fitzgerald, D. J.
(2001). Genetic variation in glycoprotein IIb/IIIa (GPIIb/IIIa) as a determinant of the responses to an oral GPIIb/IIIa antagonist in patients with unstable coronary syndromes. Blood
98: 3256-3260
[Abstract][Full Text]
Undas, A., Brummel, K., Musial, J., Mann, K. G., Szczeklik, A.
(2001). PlA2 Polymorphism of {beta}3 Integrins Is Associated With Enhanced Thrombin Generation and Impaired Antithrombotic Action of Aspirin at the Site of Microvascular Injury. Circulation
104: 2666-2672
[Abstract][Full Text]
Barakat, K., Kennon, S., Hitman, G. A., Aganna, E., Price, C. P., Mills, P. G., Ranjadayalan, K., North, B., Clarke, H., Timmis, A. D.
(2001). Interaction between smoking and the glycoprotein IIIa P1A2 polymorphism in Non-ST-elevation acute coronary syndromes. J Am Coll Cardiol
38: 1639-1643
[Abstract][Full Text]
Cadroy, Y., Sakariassen, K. S., Charlet, J.-P., Thalamas, C., Boneu, B., Sie, P.
(2001). Role of 4 platelet membrane glycoprotein polymorphisms on experimental arterial thrombus formation in men. Blood
98: 3159-3161
[Abstract][Full Text]
Agema, W. R. P., Jukema, J. W., Pimstone, S. N., Kastelein, J. J. P.
(2001). Genetic aspects of restenosis after percutaneous coronary interventions;towards more tailored therapy. Eur Heart J
22: 2058-2074
O'Shaughnessy, K. M, Fu, B., Downing, S., Morris, N. H
(2001). Thrombophilic polymorphisms in pre-eclampsia: altered frequency of the functional 98C>T polymorphism of glycoprotein IIIa. J. Med. Genet.
38: 775-777
[Full Text]
Kandzari, D. E., Goldschmidt-Clermont, P. J.
(2001). Platelet polymorphisms and ischemic heart disease: moving beyond traditional risk factors. J Am Coll Cardiol
38: 1028-1032
[Full Text]
Hessner, M. J., Dinauer, D. M., Kwiatkowski, R., Neri, B., Raife, T. J.
(2001). Age-dependent Prevalence of Vascular Disease-associated Polymorphisms among 2689 Volunteer Blood Donors. Clin. Chem.
47: 1879-1884
[Abstract][Full Text]
Kunicki, T. J., Ruggeri, Z. M.
(2001). Platelet Collagen Receptors and Risk Prediction in Stroke and Coronary Artery Disease. Circulation
104: 1451-1453
[Full Text]
Feng, D., Lindpaintner, K., Larson, M. G., O'Donnell, C. J., Lipinska, I., Sutherland, P. A., Mittleman, M., Muller, J. E., D'Agostino, R. B., Levy, D., Tofler, G. H.
(2001). Platelet Glycoprotein IIIa PlA Polymorphism, Fibrinogen, and Platelet Aggregability: The Framingham Heart Study. Circulation
104: 140-144
[Abstract][Full Text]
Wu, K. K., Willerson, J. T.
(2001). Monitoring Platelet Function in Glycoprotein IIb/IIIa Inhibitor Therapy. Circulation
103: 2528-2530
[Full Text]
Spooner, P. M., Albert, C., Benjamin, E. J., Boineau, R., Elston, R. C., George, A. L. Jr, Jouven, X., Kuller, L. H., MacCluer, J. W., Marban, E., Muller, J. E., Schwartz, P. J., Siscovick, D. S., Tracy, R. P., Zareba, W., Zipes, D. P.
(2001). Sudden Cardiac Death, Genes, and Arrhythmogenesis : Consideration of New Population and Mechanistic Approaches From a National Heart, Lung, and Blood Institute Workshop, Part II. Circulation
103: 2447-2452
[Abstract][Full Text]
Bennett, J. S., Catella-Lawson, F., Rut, A. R., Vilaire, G., Qi, W., Kapoor, S. C., Murphy, S., FitzGerald, G. A.
(2001). Effect of the PlA2 alloantigen on the function of {beta}3-integrins in platelets. Blood
97: 3093-3099
[Abstract][Full Text]
Williams, M. S., Bray, P. F.
(2001). Genetics of Arterial Prothrombotic Risk States. Exp. Biol. Med.
226: 409-419
[Abstract][Full Text]
Boudreaux, M. K., Lipscomb, D. L.
(2001). Clinical, Biochemical, and Molecular Aspects of Glanzmann's Thrombasthenia in Humans and Dogs. Vet Pathol
38: 249-260
[Abstract][Full Text]
Walter, D.H, Schachinger, V, Elsner, M, Mach, S, Dimmeler, S, Auch-Schwelk, W, Zeiher, A.M
(2001). Statin therapy is associated with reduced restenosis rates after coronary stent implantation in carriers of the PlA2allele of the platelet glycoprotein IIIa gene. Eur Heart J
22: 587-595
[Abstract]
Ilveskero, S., Siljander, P., Lassila, R.
(2001). Procoagulant Activity on Platelets Adhered to Collagen or Plasma Clot. Arterioscler. Thromb. Vasc. Bio.
21: 628-635
[Abstract][Full Text]
Mathew, J. P., Rinder, C. S., Howe, J. G., Fontes, M., Crouch, J., Newman, M. F., Phillips-Bute, B., Smith, B. R.
(2001). Platelet PlA2 polymorphism enhances risk of neurocognitive decline after cardiopulmonary bypass. Ann. Thorac. Surg.
71: 663-666
[Abstract][Full Text]
Sykes, T C F, Fegan, C, Mosquera, D
(2000). Thrombophilia, polymorphisms, and vascular disease. Mol. Pathol.
53: 300-306
[Abstract][Full Text]
Aleksic, N., Juneja, H., Folsom, A. R., Ahn, C., Boerwinkle, E., Chambless, L. E., Wu, K. K.
(2000). Platelet PlA2 Allele and Incidence of Coronary Heart Disease : Results From the Atherosclerosis Risk In Communities (ARIC) Study. Circulation
102: 1901-1905
[Abstract][Full Text]
Roest, M., Banga, J. D., Grobbee, D. E., de Groot, P. G., Sixma, J. J., Tempelman, M. J., van der Schouw, Y. T.
(2000). Homozygosity for 807 T Polymorphism in {alpha}2 Subunit of Platelet {alpha}2{beta}1 Is Associated With Increased Risk of Cardiovascular Mortality in High-Risk Women. Circulation
102: 1645-1650
[Abstract][Full Text]
Mikkelsson, J., Perola, M., Laippala, P., Penttila, A., Karhunen, P. J.
(2000). Glycoprotein IIIa PlA1/A2 polymorphism and sudden cardiac death. J Am Coll Cardiol
36: 1317-1323
[Abstract][Full Text]
Hassan, A., Markus, H. S.
(2000). Genetics and ischaemic stroke. Brain
123: 1784-1812
[Abstract][Full Text]
Kastrati, A., Koch, W., Gawaz, M., Mehilli, J., Bottiger, C., Schomig, K., von Beckerath, N., Schomig, A.
(2000). PlA polymorphism of glycoprotein IIIa and risk of adverse events after coronary stent placement. J Am Coll Cardiol
36: 84-89
[Abstract][Full Text]
Goldschmidt-Clermont, P. J., Cooke, G. E., Eaton, G. M., Binkley, P. F.
(2000). PlA2, a variant of GPIIIa implicated in coronary thromboembolic complications. J Am Coll Cardiol
36: 90-93
[Full Text]
Yokota, M., Ichihara, S., Lin, T.-L., Nakashima, N., Yamada, Y.
(2000). Association of a T29->C Polymorphism of the Transforming Growth Factor-{beta}1 Gene With Genetic Susceptibility to Myocardial Infarction in Japanese. Circulation
101: 2783-2787
[Abstract][Full Text]
Wilcox, D. A., Olsen, J. C., Ishizawa, L., Bray, P. F., French, D. L., Steeber, D. A., Bell, W. R., Griffith, M., White, G. C. II
(2000). Megakaryocyte-targeted synthesis of the integrin beta 3-subunit results in the phenotypic correction of Glanzmann thrombasthenia. Blood
95: 3645-3651
[Abstract][Full Text]
Michelson, A. D., Furman, M. I., Goldschmidt-Clermont, P., Mascelli, M. A., Hendrix, C., Coleman, L., Hamlington, J., Barnard, M. R., Kickler, T., Christie, D. J., Kundu, S., Bray, P. F.
(2000). Platelet GP IIIa PlA Polymorphisms Display Different Sensitivities to Agonists. Circulation
101: 1013-1018
[Abstract][Full Text]
Lane, D. A., Grant, P. J.
(2000). Role of hemostatic gene polymorphisms in venous and arterial thrombotic disease. Blood
95: 1517-1532
[Full Text]
Matsubara, Y., Murata, M., Maruyama, T., Handa, M., Yamagata, N., Watanabe, G., Saruta, T., Ikeda, Y.
(2000). Association between diabetic retinopathy and genetic variations in alpha 2beta 1 integrin, a platelet receptor for collagen. Blood
95: 1560-1564
[Abstract][Full Text]
Bussel, J. B., Kunicki, T. J., Michelson, A. D.
(2000). Platelets: New Understanding of Platelet Glycoproteins and Their Role in Disease. ASH Education Book
2000: 222-240
[Abstract][Full Text]
SALIDO, E., MARTÍN, B., BARRIOS, Y., LINARES, J. D., HERNÁNDEZ, D., COBOS, M., CHECA, M. D., HORTAL, L., FERNÁNDEZ, A., GARCÍA, J. J., TORRES, A.
(1999). The PlA2 Polymorphism of the Platelet Glycoprotein IIIA Gene as a Risk Factor for Acute Renal Allograft Rejection. J. Am. Soc. Nephrol.
10: 2599-2605
[Abstract][Full Text]
Batalla, A., Reguero, J. R., Cubero, G. I., Coto, E.
(1999). Prothrombotic Genetic Risk Factors and Myocardial Infarction at Young Age. Blood
94: 3959-3960
[Full Text]
Hooper, W. C., Lally, C., Austin, H., Benson, J., Dilley, A., Wenger, N. K., Whitsett, C., Rawlins, P., Evatt, B. L.
(1999). The Relationship Between Polymorphisms in the Endothelial Cell Nitric Oxide Synthase Gene and the Platelet GPIIIa Gene With Myocardial Infarction and Venous Thromboembolism in African Americans. Chest
116: 880-886
[Abstract][Full Text]
Cheng, S., Grow, M. A., Pallaud, C., Klitz, W., Erlich, H. A., Visvikis, S., Chen, J. J., Pullinger, C. R., Malloy, M. J., Siest, G., Kane, J. P.
(1999). A Multilocus Genotyping Assay for Candidate Markers of Cardiovascular Disease Risk. Genome Res
9: 936-949
[Abstract][Full Text]
Mikkelsson, J., Perola, M., Laippala, P., Savolainen, V., Pajarinen, J., Lalu, K., Penttila, A., Karhunen, P. J.
(1999). Glycoprotein IIIa PlA Polymorphism Associates With Progression of Coronary Artery Disease and With Myocardial Infarction in an Autopsy Series of Middle-Aged Men Who Died Suddenly. Arterioscler. Thromb. Vasc. Bio.
19: 2573-2578
[Abstract][Full Text]
Ardissino, D., Mannucci, P.M., Merlini, P.A., Duca, F., Fetiveau, R., Tagliabue, L., Tubaro, M., Galvani, M., Ottani, F., Ferrario, M., Corral, J., Margaglione, M.
(1999). Prothrombotic Genetic Risk Factors in Young Survivors of Myocardial Infarction. Blood
94: 46-51
[Abstract][Full Text]
Unkelbach, K., Gardemann, A., Kostrzewa, M., Philipp, M., Tillmanns, H., Haberbosch, W.
(1999). A New Promoter Polymorphism in the Gene of Lipopolysaccharide Receptor CD14 Is Associated With Expired Myocardial Infarction in Patients With Low Atherosclerotic Risk Profile. Arterioscler. Thromb. Vasc. Bio.
19: 932-938
[Abstract][Full Text]
Feng, D., Lindpaintner, K., Larson, M. G., Rao, V. S., O'Donnell, C. J., Lipinska, I., Schmitz, C., Sutherland, P. A., Silbershatz, H., D'Agostino, R. B., Muller, J. E., Myers, R. H., Levy, D., Tofler, G. H.
(1999). Increased Platelet Aggregability Associated With Platelet GPIIIa PlA2 Polymorphism : The Framingham Offspring Study. Arterioscler. Thromb. Vasc. Bio.
19: 1142-1147
[Abstract][Full Text]
Kastrati, A., Schomig, A., Seyfarth, M., Koch, W., Elezi, S., Bottiger, C., Mehilli, J., Schomig, K., von Beckerath, N.
(1999). PlA Polymorphism of Platelet Glycoprotein IIIa and Risk of Restenosis After Coronary Stent Placement. Circulation
99: 1005-1010
[Abstract][Full Text]
Anderson, J. L., King, G. J., Bair, T. L., Elmer, S. P., Muhlestein, J. B., Habashi, J., Carlquist, J. F.
(1999). Associations between a polymorphism in the gene encoding glycoprotein IIIa and myocardial infarction or coronary artery disease. J Am Coll Cardiol
33: 727-733
[Abstract][Full Text]
Bihour, C., Durrieu-Jais, C., Macchi, L., Poujol, C., Coste, P., Besse, P., Nurden, P., Nurden, A. T.
(1999). Expression of Markers of Platelet Activation and the Interpatient Variation in Response to Abciximab. Arterioscler. Thromb. Vasc. Bio.
19: 212-219
[Abstract][Full Text]
Gawaz, M., Neumann, F.-J., Schomig, A.
(1999). Evaluation of Platelet Membrane Glycoproteins in Coronary Artery Disease : Consequences for Diagnosis and Therapy. Circulation
99
: e1-e11
[Full Text]
Wang, R., Newman, P. J.
(1998). Adhesive and Signaling Properties of a Naturally Occurring Allele of Glycoprotein IIIa With an Amino Acid Substitution Within the Ligand Binding Domain---The Pena/Penb Platelet Alloantigenic Epitopes. Blood
92: 3260-3267
[Abstract][Full Text]
Gonzalez-Conejero, R., Lozano, M. L., Rivera, J., Corral, J., Iniesta, J. A., Moraleda, J. M., Vicente, V.
(1998). Polymorphisms of Platelet Membrane Glycoprotein Ibalpha Associated With Arterial Thrombotic Disease. Blood
92: 2771-2776
[Abstract][Full Text]
Batalla, A., Cubero, G. I., Reguero, J. R., Coto, E., Carter, A. M., Grant, B. P. J.
(1998). Platelet PlA Polymorphism, Myocardial Infarction, and Extent of Coronary Artery Disease • Response. Circulation
98: 826-827
[Full Text]
Carter, A. M., Catto, A. J., Bamford, J. M., Grant, P. J.
(1998). Platelet GP IIIa PlA and GP Ib Variable Number Tandem Repeat Polymorphisms and Markers of Platelet Activation in Acute Stroke. Arterioscler. Thromb. Vasc. Bio.
18: 1124-1131
[Abstract][Full Text]
Berger, G. M. B., Pegoraro, R. J., Patel, S. B., Naidu, P., Rom, L., Hidaka, H., Marais, A. D., Jadhav, A., Naoumova, R. P., Thompson, G. R.
(1998). HMG-CoA reductase is not the site of the primary defect in phytosterolemia. J. Lipid Res.
39: 1046-1054
[Abstract][Full Text]
Wagner, K. R., Giles, W. H., Johnson, C. J., Ou, C.-Y., Bray, P. F., Goldschmidt-Clermont, P. J., Croft, J. B., Brown, V. K., Stern, B. J., Feeser, B. R., Buchholz, D. W., Earley, C. J., Macko, R. F., McCarter, R. J., Sloan, M. A., Stolley, P. D., Wityk, R. J., Wozniak, M. A., Price, T. R., Kittner, S. J.
(1998). Platelet Glycoprotein Receptor IIIa Polymorphism P1A2 and Ischemic Stroke Risk : The Stroke Prevention in Young Women Study. Stroke
29: 581-585
[Abstract][Full Text]
Simoni, M., Gromoll, J., Nieschlag, E.
(1997). The Follicle-Stimulating Hormone Receptor: Biochemistry, Molecular Biology, Physiology, and Pathophysiology. Endocr. Rev.
18: 739-773
[Abstract][Full Text]
Murata, M., Matsubara, Y., Kawano, K., Zama, T., Aoki, N., Yoshino, H., Watanabe, G., Ishikawa, K., Ikeda, Y.
(1997). Coronary Artery Disease and Polymorphisms in a Receptor Mediating Shear Stress–Dependent Platelet Activation. Circulation
96: 3281-3286
[Abstract][Full Text]
Carter, A. M., Ossei-Gerning, N., Wilson, I. J., Grant, P. J.
(1997). Association of the Platelet PlA Polymorphism of Glycoprotein IIb/IIIa and the Fibrinogen Bß 448 Polymorphism With Myocardial Infarction and Extent of Coronary Artery Disease. Circulation
96: 1424-1431
[Abstract][Full Text]
Carlsson, L. E., Greinacher, A., Spitzer, C., Walther, R., Kessler, C.
(1997). Polymorphisms of the Human Platelet Antigens HPA-1, HPA-2, HPA-3, and HPA-5 on the Platelet Receptors for Fibrinogen (GPIIb/IIIa), von Willebrand Factor (GPIb/IX), and Collagen (GPIa/IIa) Are Not Correlated With an Increased Risk for Stroke. Stroke
28: 1392-1395
[Abstract][Full Text]
Burke, A. P., Farb, A., Malcom, G. T., Liang, Y.-h., Smialek, J., Virmani, R.
(1997). Coronary Risk Factors and Plaque Morphology in Men with Coronary Disease Who Died Suddenly. NEJM
336: 1276-1282
[Abstract][Full Text]